The aim of this review was to compare third generation aromatase inhibitors (AIs) to antioestrogens and progestins in the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer.
| File name: | etmrw-evidence-use-endocrin...st-cancer_504af034d610f.pdf |
| File size: | 1.32 MB |
| Cancer Type: | Breast cancer |
| Publication Audience: | Resources for health professionals |
| Year: | 2007 |
| Document Status: | Research and data reports This resource is 5 years or older. It includes data or research findings at an earlier point in time and is available to the public for research and reference purposes. |